Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ ATP13A2 Polyclonal Antibody

Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA5111322
Description
Immunogen sequence: EIRDKEDSSW QLFTVQVQTE AIGEGSLEPS PQSQAEDGRS QAAVGAVPEG AWKDTAQLHK SEEAVSVGQK RVLRYYLFQG QRYIWIET.
Neurodegenerative disorders such as Parkinson and Alzheimer disease cause motor and cognitive dysfunction and belong to a heterogeneous group of common and disabling disorders. ATP13A2, otherwise known as PARK9, is a neuronal P-type ATPase gene underlying an autosomal recessive form of early-onset parkinsonism with pyramidal degeneration and dementia. ATP13A2 protein is located in the membrane of these lysosomes and is formed most strongly in the brain, especially in the substantia nigra, a brain region which is known to play a central role in Parkinson's disease.
Specifications
ATP13A2 | |
Polyclonal | |
Unconjugated | |
ATP13A2 | |
1110012E06Rik; AA589443; AT132 antibody; Atp13a2; ATPase 13A2; ATPase type 13A2; Cation-transporting ATPase 13A2; CLN12; HSA9947; HSA9947 antibody; KRPPD; PARK9; probable cation-transporting ATPase 13A2; putative ATPase; RGD1307977; RP1-37C10.4 | |
Rabbit | |
Antigen Affinity Chromatography | |
RUO | |
23400 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin) | |
0.40 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
Q9NQ11 | |
ATP13A2 | |
Recombinant Protein corresonding to Human ATP13A2. Recombinant protein control fragment (Product #RP-103955). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction